These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33622466)

  • 1. Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South Africa.
    Leavitt SV; Jacobson KR; Ragan EJ; Bor J; Hughes J; Bouton TC; Dolby T; Warren RM; Jenkins HE
    Emerg Infect Dis; 2021; 27(3):728-739. PubMed ID: 33622466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using routinely collected laboratory data to identify high rifampicin-resistant tuberculosis burden communities in the Western Cape Province, South Africa: A retrospective spatiotemporal analysis.
    McIntosh AI; Jenkins HE; White LF; Barnard M; Thomson DR; Dolby T; Simpson J; Streicher EM; Kleinman MB; Ragan EJ; van Helden PD; Murray MB; Warren RM; Jacobson KR
    PLoS Med; 2018 Aug; 15(8):e1002638. PubMed ID: 30130377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Travel distance to rifampicin-resistant tuberculosis treatment and its impact on loss to follow-up: the importance of continued RR-TB treatment decentralization in South Africa.
    McNabb KC; Bergman AJ; Patil A; Lowensen K; Mthimkhulu N; Budhathoki C; Perrin N; Farley JE
    BMC Public Health; 2024 Feb; 24(1):578. PubMed ID: 38389038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of compensatory evolution in the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in Cape Town, South Africa: a genomic epidemiology study.
    Goig GA; Menardo F; Salaam-Dreyer Z; Dippenaar A; Streicher EM; Daniels J; Reuter A; Borrell S; Reinhard M; Doetsch A; Beisel C; Warren RM; Cox H; Gagneux S
    Lancet Microbe; 2023 Jul; 4(7):e506-e515. PubMed ID: 37295446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular detection and characterization of resistant genes in Mycobacterium tuberculosis complex from DNA isolated from tuberculosis patients in the Eastern Cape province South Africa.
    Bhembe NL; Nwodo UU; Govender S; Hayes C; Ndip RN; Okoh AI; Green E
    BMC Infect Dis; 2014 Sep; 14():479. PubMed ID: 25186245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa.
    Oostvogels S; Ley SD; Heupink TH; Dippenaar A; Streicher EM; De Vos E; Meehan CJ; Dheda K; Warren R; Van Rie A
    Microb Genom; 2022 Apr; 8(4):. PubMed ID: 35471145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organisation of care for people receiving drug-resistant tuberculosis treatment in South Africa: a mixed methods study.
    Dickson L; Le Roux SR; Mitrani L; Hill J; Jassat W; Cox H; Mlisana K; Black J; Loveday M; Grant A; Kielmann K; Ndjeka N; Moshabela M; Nicol M
    BMJ Open; 2023 Nov; 13(11):e067121. PubMed ID: 37977868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa.
    Evans D; Sineke T; Schnippel K; Berhanu R; Govathson C; Black A; Long L; Rosen S
    BMC Health Serv Res; 2018 Dec; 18(1):973. PubMed ID: 30558670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa.
    Kullin B; Wojno J; Abratt V; Reid SJ
    Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):163-175. PubMed ID: 27696234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.
    Seddon JA; Hesseling AC; Marais BJ; Jordaan A; Victor T; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):928-33. PubMed ID: 22583610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis.
    Mvelase NR; Balakrishna Y; Lutchminarain K; Mlisana K
    BMJ Open; 2019 Nov; 9(11):e031663. PubMed ID: 31699736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa.
    Salaam-Dreyer Z; Streicher EM; Sirgel FA; Menardo F; Borrell S; Reinhard M; Doetsch A; Cudahy PGT; Mohr-Holland E; Daniels J; Dippenaar A; Nicol MP; Gagneux S; Warren RM; Cox H
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0036421. PubMed ID: 34460307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial heterogeneity of extensively drug resistant-tuberculosis in Western Cape Province, South Africa.
    Sy KTL; Leavitt SV; de Vos M; Dolby T; Bor J; Horsburgh CR; Warren RM; Streicher EM; Jenkins HE; Jacobson KR
    Sci Rep; 2022 Jun; 12(1):10844. PubMed ID: 35760977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa.
    Barnard M; Albert H; Coetzee G; O'Brien R; Bosman ME
    Am J Respir Crit Care Med; 2008 Apr; 177(7):787-92. PubMed ID: 18202343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-resistant tuberculosis among HIV-infected patients starting antiretroviral therapy in Durban, South Africa.
    Hom JK; Wang B; Chetty S; Giddy J; Mazibuko M; Allen J; Walensky RP; Losina E; Freedberg KA; Bassett IV
    PLoS One; 2012; 7(8):e43281. PubMed ID: 22912845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients' experiences in the era of rapid molecular diagnostic tests.
    Naidoo P; van Niekerk M; du Toit E; Beyers N; Leon N
    BMC Health Serv Res; 2015 Oct; 15():488. PubMed ID: 26511931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A historical review of XDR tuberculosis in the Western Cape province of South Africa.
    Symons G; Shean K; Pietersen E; Van Zyl Smit R; Pool L; Davids M; Willcox P; Dheda K
    S Afr Med J; 2011 Sep; 101(9):636-8. PubMed ID: 21920174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa.
    Cox H; Ramma L; Wilkinson L; Azevedo V; Sinanovic E
    Trop Med Int Health; 2015 Oct; 20(10):1337-45. PubMed ID: 25975868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa.
    Evans D; Schnippel K; Govathson C; Sineke T; Black A; Long L; Berhanu R; Rosen S
    PLoS One; 2017; 12(7):e0181238. PubMed ID: 28746344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution and Clonality of drug-resistant tuberculosis in South Africa.
    Said H; Ratabane J; Erasmus L; Gardee Y; Omar S; Dreyer A; Ismail F; Bhyat Z; Lebaka T; van der Meulen M; Gwala T; Adelekan A; Diallo K; Ismail N
    BMC Microbiol; 2021 May; 21(1):157. PubMed ID: 34044775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.